NewsPronto

 

PR Newswire

PTC Therapeutics Announces Initiation of Phase 2/3 Clinical Trial in Australia to Evaluate PTC299 for the Treatment of COVID-19

  • Written by PR Newswire Asia - News Pronto RSS

– Oral treatment with novel dual-mechanism of action has the potential to address the two critical elements of COVID-19: viral replication and uncontrolled inflammatory response –

– Randomized, double-blind, placebo-controlled, Phase 2/3 clinical study with two stages initiated at several sites in Australia

– Also...

Read more: PTC Therapeutics Announces Initiation of Phase 2/3 Clinical Trial in Australia to Evaluate PTC299...